MAPT and depressive symptom measurement: According to PET studies deposition, tau deposition might be related to cognitive decline in patients with depression [41,42], but some results also indicated that tau deposition might play a role in the pathophysiology of MDD, suggesting tau deposition as a signal of neuronal dysfunction [40].